| Literature DB >> 32790661 |
Benjamin F Bigelow, Olive Tang, Gregory R Toci, Norberth Stracker, Fatima Sheikh, Kara M Jacobs Slifka, Shannon A Novosad, John A Jernigan, Sujan C Reddy, Morgan J Katz.
Abstract
SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), can spread rapidly in nursing homes once it is introduced (1,2). To prevent outbreaks, more data are needed to identify sources of introduction and means of transmission within nursing homes. Nursing home residents who receive hemodialysis (dialysis) might be at higher risk for SARS-CoV-2 infections because of their frequent exposures outside the nursing home to both community dialysis patients and staff members at dialysis centers (3). Investigation of a COVID-19 outbreak in a Maryland nursing home (facility A) identified a higher prevalence of infection among residents undergoing dialysis (47%; 15 of 32) than among those not receiving dialysis (16%; 22 of 138) (p<0.001). Among residents with COVID-19, the 30-day hospitalization rate among those receiving dialysis (53%) was higher than that among residents not receiving dialysis (18%) (p = 0.03); the proportion of dialysis patients who died was 40% compared with those who did not receive dialysis (27%) (p = 0.42).Careful consideration of infection control practices throughout the dialysis process (e.g., transportation, time spent in waiting areas, spacing of machines, and cohorting), clear communication between nursing homes and dialysis centers, and coordination of testing practices between these sites are critical to preventing COVID-19 outbreaks in this medically vulnerable population.Entities:
Mesh:
Year: 2020 PMID: 32790661 PMCID: PMC7440122 DOI: 10.15585/mmwr.mm6932e4
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586
FIGURE 1SARS-CoV-2 testing results among residents of a nursing home receiving or not receiving dialysis — Maryland, April 2020
Number of residents who had positive test results for SARS-CoV-2 RNA among facility A residents (N = 170), overall and by residence floor and dialysis schedule — Maryland, April 16–30, 2020
| Characteristic | No. of residents | No. (%) of cases |
|---|---|---|
|
| ||
| Not receiving dialysis | 138 | 22 (16) |
| Receiving dialysis | 32 | 15 (47) |
|
| ||
| First floor | 7 | 2 (29) |
| Second floor | 25 | 13 (52) |
|
| ||
| Monday/Wednesday/Friday | 19 | 9 (47) |
| Shift 1 | 4 | 0 (0) |
| Shift 2 | 3 | 1 (33) |
| Shift 3 | 12 | 8 (67) |
| Tuesday/Thursday/Saturday | 13 | 6 (46) |
| Shift 1 | 6 | 3 (50) |
| Shift 2 | 6 | 2 (33) |
| Shift 3 | 1 | 1 (100) |
FIGURE 2Distribution of COVID-19 cases among facility A residents receiving or not receiving dialysis, by floor* — Maryland, April 2020
Abbreviations: COVID-19 = coronavirus disease 2019; D = room of resident receiving dialysis.
* All dialysis treatments were completed in the dialysis center, which was co-located on site. Symptom-based testing referred to targeted testing of residents who were experiencing at least one of the following symptoms: fever >99°F (37.2°C), cough, malaise, headache, or upper respiratory symptoms. Facility-wide testing refers to the testing of all facility A residents who had not previously had test results positive for SARS-CoV-2, regardless of symptoms.